for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Global Health 2009

Modified polio vaccine extends lives in U.S. brain cancer study

Posted

More than one in five patients with an advanced brain cancer treated with a genetically modified polio vaccine were alive after three years, compared with just 4 percent who received standard treatment, according to U.S. researchers. Stuart McDill reports.

Global Health 2009

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up